stocksKILITCH
KILITCH

Kilitch Drugs (India) Ltd.

172.40+0.0 (+0.01%)
26 Aug, 12:00 AM

Annual Reports and Financial Documents

Kilitch Drugs (India) Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Kilitch Drugs (India) Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Monitoring Agency Report18 Aug 2026
    Announcement under Regulation 30 (LODR)-Monitoring Agency Report
    We are submitting herewith the monitoring agency report
  2. Newspaper Publication18 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    We are submitting herewith the publication of extract of the financial results for the quarter ended 30th June 2026
  3. Outcome of Board Meeting13 Aug 2026
    Board Meeting Outcome for Financial Results For The Quarter Ended 30Th June 2026
    Submission of financial results for the quarter ended 30th June 2026
  4. Board Meeting10 Aug 2026
    Board Meeting Intimation for Considering And Approval Of Unaudited Financial Results For The Quarter Ended 30Th June, 2026
    Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve unaudited standalone and ....
  5. Newspaper Publication4 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    We are submitting herewith the copy of the newspaper publication of extract of AGM Notice
  6. General1 Aug 2026
    AGM Notice - Physical Intimation To Sharehoders
    We are submitting the copy of Physical intimation made to the shareholders whose email address was not registered
  7. General1 Aug 2026
    Intimation Of Book Closure
    We are submitting the intimation of Book Closure
  8. Reg. 34 (1) Annual Report1 Aug 2026
    Reg. 34 (1) Annual Report.
    We are submitting herewith the annual report for the FY 2025-26
  9. AGM1 Aug 2026
    Notice Of Annual General Meeting
    We are hereby submitting the notice of Annual General Meeting schedule to be held on Thursday, 27th August, 2026
  10. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20188 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    We are submitting herewith the certification under regulation 74(5) of SEBI (DP) Regulations
  11. Closure of Trading Window26 Jun 2026
    Closure of Trading Window
    We are submitting herewith the intimation of Closure of window
  12. General17 Jun 2026
    Announcement Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 - Commencement Of Nutraceutical Manufacturing Block Of Our New Plant
    We are pleased to inform you that we have commenced the Nutraceutical Manufacturing Block of our new plant located at 24/2/1/1 Maldev, Pen, Raigad, Maharashtra India today. i.e 17th June, 2026
  13. Reg.24(A)-Annual Secretarial Compliance27 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    We are hereby submitting annual secretarial compliance report for the year ended 31st March, 2026
  14. Newspaper Publication18 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    We are submitting hereby copy of newspaper publication of the extract of financial results for the quarter ended 31st March, 2026
  15. Outcome of Board Meeting15 May 2026
    Board Meeting Outcome for Submission Of Audited Standalone And Consolidated Financial Results For The Quarter Ended 31St March, 2026
    We are hereby submitting audited standalone and consolidated financial results of the Company for the quarter ended 31st March, 2026
  16. Monitoring Agency Report15 May 2026
    Announcement under Regulation 30 (LODR)-Monitoring Agency Report
    We are hereby submitting the monitoring agency report for the quarter ended 31st March, 2026
  17. Board Meeting7 May 2026
    Board Meeting Intimation for Considering And Approval Of The Audited Financial Results For The Quarter And Year Ended 31St March 2026
    Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 ,inter alia, to consider and approve the audited financial results ....
  18. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201814 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    We are hereby submitting certificate under regulation 74(5) of SEBI (DP) Regulations received from MUFG Intime India Private Limited, RTA of the Company
  19. Outcome without intimation25 Mar 2026
    Board Meeting Outcome for Allotment Of Bonus Equity Shares
    Board approved the allotment of bonus equity shares in the ratio of 1:1
  20. Closure of Trading Window25 Mar 2026
    Closure of Trading Window
    Closure of Trading Window

Frequently Asked Questions

Where can I download the annual report of Kilitch Drugs (India) Ltd.?
Annual reports of Kilitch Drugs (India) Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Kilitch Drugs (India) Ltd.?
Quarterly earnings results and presentations of Kilitch Drugs (India) Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Kilitch Drugs (India) Ltd. publish earnings call transcripts?
Earnings call transcripts of Kilitch Drugs (India) Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Kilitch Drugs (India) Ltd.?
Investor presentations and annual day presentations of Kilitch Drugs (India) Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Kilitch Drugs (India) Ltd.?
Corporate announcements and regulatory filings of Kilitch Drugs (India) Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Kilitch Drugs (India) Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Kilitch Drugs (India) Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Kilitch Drugs (India) Ltd.?
The ISIN (International Securities Identification Number) of Kilitch Drugs (India) Ltd. is INE729D01010. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Kilitch Drugs (India) Ltd. listed?
Kilitch Drugs (India) Ltd. is listed on NSE and BSE. The NSE symbol is KILITCH and the BSE code is -.
Where can I find the shareholding pattern of Kilitch Drugs (India) Ltd.?
The quarterly shareholding pattern of Kilitch Drugs (India) Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Kilitch Drugs (India) Ltd. on Sharpely?
Share price data for Kilitch Drugs (India) Ltd. is updated as of 26 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.